Delivery Order SPE2DX15D5019-SR18
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $117,046.48, is for a prime vendor pharmaceutical branch in Philadelphia. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $77,682.96, is for a Prime Vendor Pharmacy Branch in Philadelphia. It is a firm fixed-price delivery order contract type without a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,040.50 Firm Fixed Price delivery order contract is for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $91,362.31 with a firm fixed price. The contract is for the Prime Vendor Pharmaceutical Branch-Philadelphia, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $157,566.90, is a delivery order for a Prime Vendor Pharmacy Branch in Philadelphia. It has a firm fixed price pricing type and an ultimate completion date of November 22, 2016. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $187,492.00, is for a prime vendor pharmacy branch in Philadelphia and has a firm fixed price delivery order type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $140,251.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the prime vendor pharmaceutical branch in Philadelphia, with a firm fixed price pricing type. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $177,231.85, is a delivery order for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract is Firm Fixed Price with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $85,992.69, is a Firm Fixed Price Delivery Order that supports the Prime Vendor Pharmaceutical Branch in Philadelphia. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $102,897.95, is a delivery order under the Prime Vendor Pharmaceutical Branch-Philadelphia contract with a period of performance through January 13, 2016. The contract is a firm-fixed price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- SPE2DX15D5019Indefinite Delivery Contract
- SPE2DX15D5019-SR18Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $152,769.98, is a delivery order for a Prime Vendor Pharmacy Branch in Philadelphia. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $152.8k | 2/26/16 |